Published: February 17, 2026 at 5:07 pm
Activist investor Kelso Group Holdings has announced its latest investment in CVS Group, a leading integrated veterinary service provider.
It follows the purchase of 130,000 shares at an average price of 1,387p in recent weeks. CVS’s market capitalisation was £971m at the close of business yesterday (February 16th).
On the back of the news CVS’s share price spiked to 1,408p, giving it a market cap of £989m.
Kelso, which is also an investor in NCC Group and THG, recently invested in over-50s group Saga and saw a 40 per cent rise in its investment in the first six weeks.
Sir Nigel Knowles, chairman of Kelso, said: “CVS has built a high-quality resilient platform operating in a structurally attractive market and has delivered an exceptional long-term record of consistent growth.
“Kelso’s investment reflects our conviction that the current valuation does not reflect the strength of the business, the quality of its earnings or its long-term strategic value.
“We believe disciplined capital allocation will be increasingly important in unlocking future shareholder value.
“Kelso is a supportive long-term shareholder, and we look forward to engaging constructively with management over time.”